Abstract five-MeO-DMT can be a tryptamine currently being designed as a potential antidepressant that could Screen a definite therapeutic system as a result of its special pharmacology and subjective results in comparison to common psychedelics. In this article, we parallel the relatively unique phenomenology and behavioral results of the acute and